| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034904 |
| Receipt No. | R000039753 |
| Scientific Title | Sucroferric oxyhydroxide Guanules Questionnaire survey |
| Date of disclosure of the study information | 2018/11/20 |
| Last modified on | 2019/11/18 (Ver. 6) |
| Basic information | ||
| Public title | Sucroferric oxyhydroxide Guanules Questionnaire survey | |
| Acronym | Sucroferric oxyhydroxide Guanules Questionnaire survey | |
| Scientific Title | Sucroferric oxyhydroxide Guanules Questionnaire survey | |
| Scientific Title:Acronym | Sucroferric oxyhydroxide Guanules Questionnaire survey | |
| Region |
|
|
| Condition | ||
| Condition | Improvement of hyperphosphatemia in dialysis patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Do a survey of Administration feeling of Sucroferric oxyhydroxide Guanules |
| Basic objectives2 | Others |
| Basic objectives -Others | Administration feeling |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Administration feeling |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Administered Sucroferric oxyhydroxide Guanules and hyperphosphatemia in dialysis patients
2)Patients can acquire written informed consent appropriately (excluding patients with dementia) |
|||
| Key exclusion criteria | Pharmacist judged ineligible as subject of investigation | |||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Qol Co.,Ltd. | ||||||
| Division name | Chubu Pharmacy Business Division | ||||||
| Zip code | 450-6034 | ||||||
| Address | 1-1-4, Meieki, Nakamura-ku, Nagoya, Aichi, Japan | ||||||
| TEL | 052-589-1389 | ||||||
| y-oikawa@apoplus.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | APO PLUS STATION CO., LTD. | ||||||
| Division name | CRO Division | ||||||
| Zip code | 103-0027 | ||||||
| Address | 14-1 Nihonbashi2-chome, Chuo-ku, Tokyo, Japan | ||||||
| TEL | 03-6386-9500 | ||||||
| Homepage URL | |||||||
| y-oikawa@apoplus.co.jp | |||||||
| Sponsor | |
| Institute | Qol Co.,Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kissei Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kitamachi Clinic Ethics Review Committee |
| Address | 1-1-3, Kitamachi, kichijyoji, musasino-city, Tokyo, JAPAN |
| Tel | 070-5011-8550 |
| shingo-namiki@j-smo.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | クオール薬局 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.iyaku.info/magazine/magazine_1.html | ||||||
| Number of participants that the trial has enrolled | 75 | ||||||
| Results | |||||||
| Results date posted | |||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Questionnaire survey |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039753 |